Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Sasaki, Yuto*; Sano, Aaru; Sasaki, Shinji; Iwamoto, Nobuyuki; Ouchi, Kazuki; Kitatsuji, Yoshihiro; Takaki, Naoyuki*; Maeda, Shigetaka
Journal of Nuclear Science and Technology, 61(4), p.509 - 520, 2024/04
Times Cited Count:4 Percentile:77.44(Nuclear Science & Technology)Ac is attracting attention as an alpha-emitting medical radioisotope. Since its demand is expected to increase, domestic production of
Ac is required from the viewpoint of Japan's medical research and economic security. To establish the technical bases for the
Ac production, JAEA has evaluated the radioactivity that can be produced in the experimental fast reactor Joyo and designed the concept that upgrades the existing facilities for transporting the irradiated target from Joyo to a neighboring PIE facility rapidly. Efficient
Ac Separation from
Ra irradiated in a fast reactor was studied. Ba and La were used as alternatives to Ra and Ac, respectively. By using DGA resin as an adsorbent, it can be expected that Ra and impurities generated by irradiation will be removed and Ac will be isolated. This study has revealed that Joyo can sufficiently produce
Ac as a raw material for pharmaceuticals.
Ohshima, Hiroyuki; Morishita, Masaki*; Aizawa, Kosuke; Ando, Masanori; Ashida, Takashi; Chikazawa, Yoshitaka; Doda, Norihiro; Enuma, Yasuhiro; Ezure, Toshiki; Fukano, Yoshitaka; et al.
Sodium-cooled Fast Reactors; JSME Series in Thermal and Nuclear Power Generation, Vol.3, 631 Pages, 2022/07
This book is a collection of the past experience of design, construction, and operation of two reactors, the latest knowledge and technology for SFR designs, and the future prospects of SFR development in Japan. It is intended to provide the perspective and the relevant knowledge to enable readers to become more familiar with SFR technology.
Sasaki, Yuto; Sano, Aaru; Itagaki, Wataru; Maeda, Shigetaka; Takaki, Naoyuki*
no journal, ,
no abstracts in English
Sano, Aaru; Sasaki, Yuto*; Sasaki, Shinji; Iwamoto, Nobuyuki; Ouchi, Kazuki; Kitatsuji, Yoshihiro; Maeda, Shigetaka; Takaki, Naoyuki*
no journal, ,
Ac-225 can be applied to cancer treatment of various sites, but world supply is scarce. In this study, in order to study the production of Ac-225 using fast neutrons, we evaluated the amount of Ac-225 produced by fast neutron irradiation of Joyo. Burn up calculations were performed with Ra-226 as the target using ORIGEN2.2 for the evaluation of the production amount. In addition, the uncertainty of Ac-225 production was evaluated from the nuclear reaction cross section of the target nuclide and the neutron flux of Joyo. This study showed that a large amount of Ac-225 can be produced by irradiating Ra-226 at Joyo. In the future, we will improve the accuracy of evaluation of the production amount through demonstration experiments.
Uchida, Mao*; Hirakawa, Moe*; Inoue, Keisuke*; Sano, Aaru*; Sakai, Takaaki*; Ezure, Toshiki; Tanaka, Masaaki
no journal, ,
Visualization measurements using a high-speed camera and numerical analyses were carried out for gas entrainment phenomenon due to free surface drifting vortices in an open rectangular channel. The applicability of gas core length based on numerical analyses was confirmed for drifting vortices in the open channel through the comparison with experimental results.
Sano, Aaru; Maeda, Shigetaka; Itagaki, Wataru; Sasaki, Shinji; Sasaki, Yuto*; Takaki, Naoyuki*
no journal, ,
Ac-225 is attracting attention as an alpha emitting medical radioisotope. Since its demand is expected to increase, domestic production of Ac-225 is required from the viewpoint of medical research and economic security of Japan. To establish the technical bases for the Ac-225 production, JAEA has evaluated the radioactivity can be produced in the experimental fast reactor Joyo and designed the concept that upgrades the existing facilities for transporting the irradiated target from Joyo to a neighboring PIE facility rapidly. This study has revealed that Joyo can sufficiently produce Ac-225 as a raw material for pharmaceuticals.